The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Monadia 50mcg/actuation Nasal spray, suspension



Diapharm GmbH & Co. KGPA1958/008/001

Main Information

Trade NameMonadia 50mcg/actuation Nasal spray, suspension
Active SubstancesMometasone furoate monohydrate
Dosage FormNasal spray, suspension
Licence HolderDiapharm GmbH & Co. KG
Licence NumberPA1958/008/001

Group Information

ATC CodeR01AD09 mometasone

Status

License statusAuthorised
Licence Issued10/05/2024
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version
« Back